NCT03113162View on ClinicalTrials.gov

Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis

PHASE1UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 29, 2015

Primary Completion Date

May 29, 2020

Study Completion Date

May 29, 2022

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

Autologous Hematopoietic Stem Cell

DRUG

BEAM Regimen

Reduced-intensity BEAM for Immunoablation

Trial Locations (1)

1229

RECRUITING

Makati Medical Center, Makati

Sponsors
All Listed Sponsors
lead

Makati Medical Center

OTHER